Early research (Phase 1)Study completedNCT03674177
What this trial is testing
Evaluate Different Dose Levels of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3888550A), Based on the Vaccine Safety and the Antibodies (Body Defences) Produced Following Vaccine Administration, When Given to Healthy Non-pregnant Women
Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 502